Stock Analiz

Prothena Corp. Public Ltd. Co. (PRTA) stock forecast and price target

Price $8.16 · data as of November 13, 2026

12-month price target

Average target$21.40
Upside / downside+162.3%
Analysts5
ConsensusBuy
Low $8.00Average $21.40High $36.00

Gold marker: average target · white marker: today’s price ($8.16)

Analyst ratings

Strong buy 2Buy 2Hold 2Sell 0Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$0.66+116.5%$72M
Next fiscal year
ends December 31, 2027
$-1.24−289.3%$21M
Next quarter
ends December 31, 2026
$0.53+214.9%$20M
Quarter after
ends March 31, 2027
$-0.36−152.7%$0

Consensus of the analysts covering Prothena Corp. Public Ltd., updated daily. In the last 30 days 2 estimates were raised and 0 lowered.

Frequently asked questions

What is the Prothena Corp. Public Ltd. stock price target?

The average 12-month target from 5 analysts is $21.40, 162.3% above the current price of $8.16 Targets range from $8.00 to $36.00.

Is Prothena Corp. Public Ltd. a buy according to analysts?

The consensus rating is “Buy” (2 strong buy, 2 buy, 2 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Prothena Corp. Public Ltd. expected to earn?

Analysts expect EPS of $0.66 for the fiscal year ending December 31, 2026 and $-1.24 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.